{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:51:24Z","timestamp":1785235884672,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05293-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:14:42Z","timestamp":1776662082000},"page":"15027-15037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ruxolitinib attenuates diethylnitrosamine-induced liver injury in mice: involvement of TLR4\/MYD88\/NF-\u03baB and IL-6\/JAK\/STAT pathways"],"prefix":"10.1007","volume":"399","author":[{"given":"Doaa H.","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Hazem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"5293_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6661937","volume":"2021","author":"MA Alsahli","year":"2021","unstructured":"Alsahli MA et al (2021) 6-gingerol, a major ingredient of ginger attenuates diethylnitrosamine-induced liver injury in rats through the modulation of oxidative stress and anti-inflammatory activity. Mediators Inflamm 2021:6661937","journal-title":"Mediators Inflamm"},{"issue":"3","key":"5293_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12011-022-03221-7","volume":"201","author":"MMM Badawy","year":"2023","unstructured":"Badawy MMM, Abdel-Hamid GR, Mohamed HE (2023) Antitumor activity of chitosan-coated iron oxide nanocomposite against hepatocellular carcinoma in animal models. Biol Trace Elem Res 201(3):1274\u20131285","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"5293_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.15430\/JCP.2016.21.3.173","volume":"21","author":"JM Cho","year":"2016","unstructured":"Cho JM et al (2016) Protective effect of boiled and freeze-dried mature silkworm larval powder against Diethylnitrosamine-induced hepatotoxicity in mice. J Cancer Prev 21(3):173\u2013181","journal-title":"J Cancer Prev"},{"key":"5293_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00389","volume":"10","author":"YF Ding","year":"2019","unstructured":"Ding YF et al (2019) Baishouwu extract suppresses the development of hepatocellular carcinoma via TLR4\/MyD88\/NF-\u03baB pathway. Front Pharmacol 10:389","journal-title":"Front Pharmacol"},{"key":"5293_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01186","volume":"9","author":"EM Elli","year":"2019","unstructured":"Elli EM et al (2019) Mechanisms underlying the anti-inflammatory and immunosuppressive activity of ruxolitinib. Front Oncol 9:1186","journal-title":"Front Oncol"},{"issue":"6","key":"5293_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s10787-022-01058-z","volume":"30","author":"M Elshal","year":"2022","unstructured":"Elshal M, Hazem SH (2022) Escin suppresses immune cell infiltration and selectively modulates Nrf2\/HO-1, TNF-\u03b1\/JNK, and IL-22\/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice. Inflammopharmacology 30(6):2317\u20132329","journal-title":"Inflammopharmacology"},{"issue":"6","key":"5293_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2013.11.005","volume":"24","author":"S Gao","year":"2013","unstructured":"Gao S et al (2013) NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell 24(6):725\u2013737","journal-title":"Cancer Cell"},{"key":"5293_CR8","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.crfs.2022.11.001","volume":"5","author":"Z Gao","year":"2022","unstructured":"Gao Z et al (2022) An iron-deficient diet prevents alcohol- or diethylnitrosamine-induced acute hepatotoxicity in mice by inhibiting ferroptosis. Curr Res Food Sci 5:2171\u20132177","journal-title":"Curr Res Food Sci"},{"issue":"1","key":"5293_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228(1):273\u2013287","journal-title":"Immunol Rev"},{"issue":"14","key":"5293_CR10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1096\/fj.06-6250fje","volume":"20","author":"A Gonz\u00e1lez-P\u00e9riz","year":"2006","unstructured":"Gonz\u00e1lez-P\u00e9riz A et al (2006) Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 20(14):2537\u20132539","journal-title":"FASEB J"},{"key":"5293_CR11","unstructured":"Haq M, Adnan\u00a0G (2026)\u00a0Ruxolitinib. [Updated 2023 Jun 5]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570600\/"},{"key":"5293_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.intimp.2018.06.026","volume":"61","author":"SH Hazem","year":"2018","unstructured":"Hazem SH (2018a) Comparison of lactate and beta-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis. Int Immunopharmacol 61:376\u2013384","journal-title":"Int Immunopharmacol"},{"key":"5293_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.intimp.2018.06.026","volume":"61","author":"SH Hazem","year":"2018","unstructured":"Hazem SH et al (2018b) Comparison of lactate and \u03b2-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis. Int Immunopharmacol 61:376\u2013384","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5293_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10517-016-3555-3","volume":"162","author":"SI Il\u2019nitskaya","year":"2016","unstructured":"Il\u2019nitskaya SI et al (2016) Stimulation of diethylnitrosamine metabolism reduces its general toxic and hepatocarcinogenic effects. Bull Exp Biol Med 162(1):98\u2013101","journal-title":"Bull Exp Biol Med"},{"key":"5293_CR15","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2147\/IJN.S196651","volume":"14","author":"MW Khan","year":"2019","unstructured":"Khan MW et al (2019) Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Int J Nanomedicine 14:3753\u20133771","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"5293_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48171-8","volume":"9","author":"JY Kim","year":"2019","unstructured":"Kim JY et al (2019) ROR\u03b1 suppresses interleukin-6-mediated hepatic acute phase response. Sci Rep 9(1):11798","journal-title":"Sci Rep"},{"key":"5293_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211073593","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar A et al (2022) Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats. Hum Exp Toxicol 41:9603271211073592","journal-title":"Hum Exp Toxicol"},{"issue":"4","key":"5293_CR18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1053\/j.gastro.2018.11.019","volume":"156","author":"S Liang","year":"2019","unstructured":"Liang S et al (2019) Nadph oxidase 1 in liver macrophages promotes inflammation and tumor development in mice. Gastroenterology 156(4):1156-1172.e6","journal-title":"Gastroenterology"},{"issue":"10","key":"5293_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/abbs\/gmaa069","volume":"52","author":"M Ma","year":"2020","unstructured":"Ma M et al (2020) STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai) 52(10):1063\u20131070","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"8","key":"5293_CR20","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.31557\/APJCP.2019.20.8.2551","volume":"20","author":"DF Mansour","year":"2019","unstructured":"Mansour DF et al (2019) The carcinogenic agent diethylnitrosamine induces early oxidative stress, inflammation and proliferation in rat liver, stomach and colon: protective effect of ginger extract. Asian Pac J Cancer Prev 20(8):2551\u20132561","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"5293_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582(1):67\u201378","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5293_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yexcr.2019.05.008","volume":"381","author":"R Rosati","year":"2019","unstructured":"Rosati R et al (2019) Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells. Exp Cell Res 381(1):105\u2013111","journal-title":"Exp Cell Res"},{"issue":"3","key":"5293_CR23","volume":"21","author":"D Schrenk","year":"2023","unstructured":"Schrenk D et al (2023) Risk assessment of N-nitrosamines in food. EFSA J 21(3):e07884","journal-title":"EFSA J"},{"key":"5293_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.toxlet.2016.08.015","volume":"261","author":"ME Shaker","year":"2016","unstructured":"Shaker ME, Ashamallah SA, El-Mesery M (2016) The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice. Toxicol Lett 261:13\u201325","journal-title":"Toxicol Lett"},{"issue":"3","key":"5293_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jsps.2022.01.007","volume":"30","author":"ME Shaker","year":"2022","unstructured":"Shaker ME, Hamed MF, Shaaban AA (2022a) Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. Saudi Pharm J 30(3):291\u2013299","journal-title":"Saudi Pharm J"},{"key":"5293_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108463","volume":"103","author":"ME Shaker","year":"2022","unstructured":"Shaker ME et al (2022b) The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice. Int Immunopharmacol 103:108463","journal-title":"Int Immunopharmacol"},{"key":"5293_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051001","author":"AM Shawky","year":"2022","unstructured":"Shawky AM et al (2022) A comprehensive overview of globally approved JAK inhibitors. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14051001","journal-title":"Pharmaceutics"},{"issue":"5","key":"5293_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V et al (2024) Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol 81(5):895\u2013910","journal-title":"J Hepatol"},{"key":"5293_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115382","volume":"208","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) JAK-STAT signaling as an ARDS therapeutic target: status and future trends. Biochem Pharmacol 208:115382","journal-title":"Biochem Pharmacol"},{"key":"5293_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714943","volume":"12","author":"H Zhu","year":"2021","unstructured":"Zhu H et al (2021) Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition. Front Immunol 12:714943","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05293-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:07:05Z","timestamp":1784776025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5293"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05293-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}